Frailty and [177Lu]Lu-PSMA-617 therapy: tools and strategies for older men with metastatic castration-resistant prostate cancer.

Pluvicto (lutetium Lu 177 vipivotide tetraxetan) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42707638

Daniele Santini; Giuseppe Ferdinando Colloca; Lucia Fratino; Matteo Bauckneht; Nicolò Borsellino

Sep 9, 2026